StockWatch
·
Medical/Dental Instruments
Management ChangeApr 30, 2026, 04:53 PM

NXGL Appoints Ian Blackman as CFO, Effective April 27, 2026

AI Summary

NEXGEL, Inc. announced the appointment of Ian Blackman, 58, as its new Chief Financial Officer, effective April 27, 2026. Mr. Blackman, a Certified Public Accountant with over 30 years of global financial leadership experience, succeeds Mr. Drapczuk. His appointment is aimed at advancing the integration of the Celularity acquisition, scaling the business, and accelerating growth. His compensation package includes a $250,000 annual base salary, performance-based cash bonuses up to 50% of his base salary for fiscal year 2026, and an initial grant of options to purchase 160,000 shares of common stock.

Key Highlights

  • Ian Blackman, 58, appointed Chief Financial Officer of NEXGEL, Inc., effective April 27, 2026.
  • Mr. Blackman succeeds Mr. Drapczuk as the Company’s principal financial and accounting officer.
  • He brings over 30 years of global financial leadership experience, including CFO roles at McIntosh Group Inc. and Diptyque/Byredo.
  • His base salary is $250,000 per year.
  • Eligible for a 2026 cash bonus up to 50% of base salary based on EBITDA targets ($4M, $6M, or $8M).
  • Received an initial grant of options to purchase 160,000 shares of common stock.
  • Options vest over four years, with 40,000 shares on the first anniversary and 120,000 shares monthly thereafter.
  • Appointment is strategic to integrate the Celularity acquisition, scale the business, and accelerate growth.